Cole Schmidtknecht, 22, had insurance but couldn’t afford to refill his asthma inhaler after the cost jumped from $70 to more ...

Drugmakers are introducing discounts and lower-cost options for consumers who have to pay for GLP-1 drugs out of pocket. News outlets look at the trend in pricing for drugs like Wegovy and Zepbound.

A decade since the first biosimilar medicine reached the U.S. market, pharmacy benefit managers are getting serious about these lower-cost versions of biologic drugs. CVS Caremark, OptumRx ...

Amjevita and Wezlana are available at both high and low list prices. As of January 1, 2025, OptumRx ... a drug], the PBM, which creates the formulary and prefers it, and the specialty pharmacy ...

1 Researchers developed an algorithm that identifies the most cost-effective billing method for specialty drugs, addressing the challenge of varying reimbursement rates between pharmacy and ...

Optum Rx announced Wednesday that it will eliminate up to 25% of reauthorizations, initially focusing on 80 drugs ... pairs eligible specialty pharmacy customers with financial resources and ...

Optum Rx is committed to making prescription drugs more affordable and the pharmacy experience simpler ... physicians and pharmacists to expand the list over time. Medication authorizations ...

March 19, 2025--(BUSINESS WIRE)--Optum Rx is committed to making prescription drugs more affordable and the pharmacy experience ... and pharmacists to expand the list over time.

The “big three” pharmacy benefit managers have imposed markups ranging from 100% to more than 7,000% on generic specialty ... a rebate based on the list price of the drug is critical to ...

OptumRx "is helping reduce out-of-pocket costs for consumers, addressing the high cost of specialty drugs through integrated cost management and simplifying the pharmacy experience for our clients ...